Seller record · Telehealth service

Ivologist

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: The pages say medications are compounded by licensed 503A and 503B U.S. partner pharmacies, and no pharmacy is named in the answers, the terms, the privacy policy or the telehealth consent. 1 more criterion also fails; see the table below.

At a glance

IvologistTelehealth service

6/8criteria passed

Price: Semaglutide first month $124, then $149 a month; tirzepatide first month $224, then $249
Sells: compounded semaglutide injectable, compounded tirzepatide injectable, and 8 more
FDA letters: None on file

Visit Ivologist See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A Texas telehealth and mobile IV service selling compounded semaglutide and tirzepatide on starter programs, an oral liposomal semaglutide, sermorelin, NAD+ and BPC-157, alongside hormone therapy. It prints a Texas business address and names no filling pharmacy.

Operating entity Ivologist Weight Loss Center, LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Ivologist's website; Ivologist's terms
S2	Prescription gating	PASS	Ivologist's assessment page; Ivologist's website; Ivologist's semaglutide page
S3	Pharmacy identification	FAIL	Ivologist's website; Ivologist's terms; Ivologist's privacy policy; Ivologist's telehealth consent
S4	Compounding disclosure	PASS	Ivologist's website; Ivologist's peptides page
S5	Analytical documentation	FAIL	Ivologist's NAD+ page; Ivologist's peptides page
S6	Business address	PASS	Ivologist's terms; Ivologist's privacy policy; Ivologist's disclaimer page
S7	Price disclosure	PASS	Ivologist's semaglutide page; Ivologist's tirzepatide page; Ivologist's GLP-1 liquid liposomal page; Ivologist's sermorelin page; Ivologist's NAD+ page; Ivologist's BPC-157 page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed provider reviews each intake in a telehealth consultation and decides whether treatment is appropriate, and every plan is reviewed by a licensed provider rather than issued automatically.Source: Ivologist's website; Ivologist's terms.

S2PASSThe start and book buttons open an assessment whose first screen asks height, weight, gender and date of birth to calculate BMI.Source: Ivologist's assessment page; Ivologist's website; Ivologist's semaglutide page.

S3FAILThe pages say medications are compounded by licensed 503A and 503B U.S. partner pharmacies, and no pharmacy is named in the answers, the terms, the privacy policy or the telehealth consent.Source: Ivologist's website; Ivologist's terms; Ivologist's privacy policy; Ivologist's telehealth consent.

S4PASSA banner on every page states that compounded medications are not FDA-approved, and the footer and the peptide catalog repeat it.Source: Ivologist's website; Ivologist's peptides page.

S5FAILThe NAD+ page describes the medication as pharmacy-compounded and quality tested, and no certificate of analysis or lot document is published.Source: Ivologist's NAD+ page; Ivologist's peptides page.

S6PASSIvologist Weight Loss Center, LLC at 26331 Tawny Way, Boerne, TX 78015, printed in the terms as its principal place of business and repeated in the privacy policy and the disclaimer.Source: Ivologist's terms; Ivologist's privacy policy; Ivologist's disclaimer page.

S7PASSCompounded semaglutide at $124 for the first month on the monthly starter plan, struck from $199, then $149 a month, or $397 paid in full for 3 months against a listed $497. Compounded tirzepatide at $224 for the first month, struck from $299, then $249 a month, or $697 for 3 months against a listed $797. The discount applies to the first order. Liposomal oral semaglutide at $299 a month on an 8-week program totaling $598. Sermorelin at $50 a week on a 4-week protocol, the NAD+ injection at $115 a month on a 2-month program, and BPC-157 at $249 for 6 weeks.Source: Ivologist's semaglutide page; Ivologist's tirzepatide page; Ivologist's GLP-1 liquid liposomal page; Ivologist's sermorelin page; Ivologist's NAD+ page; Ivologist's BPC-157 page.

S8PASSNo FDA warning letter names Ivologist or Ivologist Weight Loss Center, LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide injectable, compounded tirzepatide injectable, liposomal semaglutide (oral), sermorelin, NAD+ injectable, NAD+ nasal spray, BPC-157, testosterone replacement therapy, hormone replacement therapy, IV therapy.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells BPC-157

Visit Ivologist

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.